Significant Accounting Policies (Details Narrative) |
3 Months Ended | 6 Months Ended | 9 Months Ended | 12 Months Ended | ||||||
|---|---|---|---|---|---|---|---|---|---|---|
|
Jun. 30, 2026
USD ($)
|
Mar. 31, 2026
USD ($)
|
Jun. 30, 2025
USD ($)
|
Mar. 31, 2025
USD ($)
|
Dec. 31, 2024
USD ($)
|
Jun. 30, 2026
USD ($)
Segment
|
Jun. 30, 2025
USD ($)
|
Sep. 24, 2024
USD ($)
|
Dec. 31, 2025
USD ($)
Segment
|
Dec. 31, 2024
USD ($)
|
|
| Reorganization, Chapter 11 [Line Items] | ||||||||||
| Cash FDIC insured amount | $ 250,000 | $ 250,000 | $ 250,000 | |||||||
| Research and development expenses | $ 0 | $ 39,558 | ||||||||
| Number of operating segment | Segment | 1 | |||||||||
| Net loss | (638,726) | $ (2,008,476) | $ (660,583) | $ (538,770) | $ (862,791) | $ (2,647,202) | $ (1,199,353) | $ (654,640) | $ (6,278,191) | $ (1,517,431) |
| Tax rate | 21.00% | 21.00% | 21.00% | |||||||
| Deferred tax assets | 1,809,017 | 181,186 | $ 1,809,017 | $ 1,499,644 | $ 181,186 | |||||
| Valuation allowance | $ 1,809,017 | 181,186 | $ 1,809,017 | $ 1,499,644 | $ 181,186 | |||||
| Single Reportable Segment [Member] | ||||||||||
| Reorganization, Chapter 11 [Line Items] | ||||||||||
| Number of operating segment | Segment | 1 | |||||||||
| Predecessor [Member] | ||||||||||
| Reorganization, Chapter 11 [Line Items] | ||||||||||
| Research and development expenses | $ 39,558 | |||||||||
| Successor [Member] | ||||||||||
| Reorganization, Chapter 11 [Line Items] | ||||||||||
| Research and development expenses | $ 0 | |||||||||
| X | ||||||||||
- Definition The amount of cash deposited in financial institutions as of the balance sheet date that is insured by the Federal Deposit Insurance Corporation. No definition available.
|
| X | ||||||||||
- Definition Amount before allocation of valuation allowances of deferred tax asset attributable to deductible temporary differences and carryforwards. Reference 1: http://www.xbrl.org/2003/role/disclosureRef
|
| X | ||||||||||
- Definition Amount of deferred tax assets for which it is more likely than not that a tax benefit will not be realized. Reference 1: http://www.xbrl.org/2003/role/disclosureRef
|
| X | ||||||||||
- Definition Percentage of domestic federal statutory tax rate applicable to pretax income (loss). Reference 1: http://www.xbrl.org/2003/role/disclosureRef
|
| X | ||||||||||
- Definition The portion of profit or loss for the period, net of income taxes, which is attributable to the parent. Reference 1: http://www.xbrl.org/2003/role/disclosureRef
|
| X | ||||||||||
- Definition Number of operating segments. An operating segment is a component of an enterprise: (a) that engages in business activities from which it may earn revenues and incur expenses (including revenues and expenses relating to transactions with other components of the same enterprise), (b) whose operating results are regularly reviewed by the enterprise's chief operating decision maker to make decisions about resources to be allocated to the segment and assess its performance, and (c) for which discrete financial information is available. An operating segment may engage in business activities for which it has yet to earn revenues, for example, start-up operations may be operating segments before earning revenues. Reference 1: http://www.xbrl.org/2003/role/exampleRef
|
| X | ||||||||||
- Definition Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table. Reference 1: http://www.xbrl.org/2003/role/disclosureRef
|
| X | ||||||||||
- Definition Amount of expense for research and development. Includes, but is not limited to, cost for computer software product to be sold, leased, or otherwise marketed and writeoff of research and development assets acquired in transaction other than business combination or joint venture formation or both. Excludes write-down of intangible asset acquired in business combination or from joint venture formation or both, used in research and development activity. Reference 1: http://www.xbrl.org/2003/role/disclosureRef
|
| X | ||||||||||
- Details
|
| X | ||||||||||
- Details
|
| X | ||||||||||
- Details
|